Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Sanofi-Aventis,
Merck to Combine Animal Health Units 5:15 AM 3/9/2010
BusinessWeek
Sanofi-Aventis and Merck & Co will combine their veterinary medicine units
creating the world’s largest animal health business (combined sales over $5 billion with 14,000 employees).
...
ImmunoGen's
skin cancer drug gets orphan drug status 4:32 PM 3/8/2010
Reuters
ImmunoGen Inc's experimental skin cancer drug IMGN901 currently in an
early stage trial for the treatment of Merkel Cell Carcinoma received orphan drug designation from the US FDA
and European health regulators.
...
Roche,
Biogen suffer setback with rheumatoid arthritis drug 5:48 AM 3/8/2010
MarketWatch
Roche Holding and Biogen Idec Inc suspended a rheumatoid
arthritis program using drug candidate ocrelizumab due to safety concerns.
...
AstraZeneca
Drug Fails to Match Avastin in Test 4:32 AM 3/8/2010
BusinessWeek
AstraZeneca Plc’s experimental Recentin failed to match Roche Holding’s Avastin
in tests for use as an initial treatment against colon cancer.
...
Tolerx
hopes drug will reshape diabetes therapy 12:48 AM 3/8/2010
Boston Globe
Tolerx Inc hopes to some day offer an eight-day course of daily
intravenous infusions of otelixizumab that could help preserve patients’ natural ability to produce insulin
for years.
...
Cambodia
drug-resistant malaria stirs health fears 7:47 AM 3/7/2010
Reuters
The province of Pailin is the epicenter of strains of malaria that have
baffled healthcare experts worldwide. A dangerous new form of malaria may already be spreading across the
globe.
...
First
mesothelioma vaccine 11:59 AM 3/5/2010
Examiner.com
Researchers have developed the first vaccine for mesothelioma as reported in
American Journal of Respiratory and Critical Care Medicine.
...
Effect of InterMune lung drug
unclear 9:51 AM 3/5/2010
Reuters
The US FDA
is concerned about unclear trial results and possible side effects with InterMune Inc's pirfenidone drug to
treat lung scarring.
...
Columbia
Labs sells female hormone products to Watson 7:15 AM 3/5/2010
Reuters
Columbia Laboratories Inc agreed to sell its progesterone hormone related
products and common shares to Watson Pharmaceuticals Inc.
...
Pfizer,
BMS anti-clot drug promising in new trial 5:25 AM 3/5/2010
Reuters
Pfizer and Bristol-Myers Squibb's anti-clotting pill apixaban proved
better than standard treatment Sanofi-Aventis's Lovenox in a late-stage knee surgery trial.
...
Bristol
to seek approval of cancer drug this year 2:08 PM 3/4/2010
Reuters
Bristol-Myers Squibb is planning to seek approval this year for its
experimental cancer drug ipilimumab as a treatment for advanced melanoma. Ipilimumab also moves into
late-stage lung cancer trials.
...
Genzyme
drug fails to aid in walking 5:08 AM 3/4/2010
Boston Globe
Genzyme Corp’s and partner PTC Therapeutics Inc's experimental ataluren
treatment for muscular dystrophy failed to meet the primary goal of a 48-week study.
...
Child
seizure study finds oldest drug works best 3:38 PM 3/3/2010
Reuters
A large-scale study of three anti-epilepsy drugs found that the old
drug ethosuximide was best for treating childhood absence epilepsy. Newer lamotrigine fared the worst.
...
Medivation
shares sink after drug trial results 9:09 AM 3/3/2010
Reuters
Shares of Medivation Inc fell 70 percent after the company's experimental drug
Dimebon failed to meet the main goals in a late-stage clinical trial for Alzheimer's disease.
...
Bristol,
Allergan in pact for new pain drug 8:43 AM 3/3/2010
Reuters
Bristol-Myers Squibb and Allergan Inc entered into an agreement to develop and
commercialize Allergan's experimental drug AGN-209323 to treat neuropathic pain.
...
<- Day Earlier | Today's News
|
